S A Cannistra
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 10
- Immunology top 10%
- Immune Response and Inflammation 5
- Immune Cell Function and Interaction 4
- Hematology top 10%
- Immunology and Allergy top 10%
- Oncology top 10%
- PARP inhibition in cancer therapy 3
- Cytokine Signaling Pathways and Interactions 3
- Vascular Tumors and Angiosarcomas 2
-
- Proteoglycans and glycosaminoglycans research 3
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Thomas StröbelH LevineJames D. GriffinF. HerrmannLinda J. SwansonJonathan M. NiloffYu‐Tzu TaiJ D Griffin
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (7 papers)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
S A Cannistra
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 76
- Reproductive Medicine 236
- Immunology 368
- Hematology 141
- Immunology and Allergy 72
- Oncology 324
Countries citing papers authored by S A Cannistra
This map shows the geographic impact of S A Cannistra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Cannistra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Cannistra more than expected).
Fields of papers citing papers by S A Cannistra
This network shows the impact of papers produced by S A Cannistra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Cannistra. The network helps show where S A Cannistra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S A Cannistra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 11 | |
| 2 | 2018 | 20 | |
| 3 | 2007 | 2 | |
| 4 | 2006 | 43 | |
| 5 | 2006 | 14 | |
| 6 | In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. | 1999 | 74 |
| 7 | 1998 | 118 | |
| 8 | In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. | 1997 | 111 |
| 9 | 1996 | 56 | |
| 10 | 1996 | 13 | |
| 11 | 1995 | 81 | |
| 12 | Functional heterogeneity of CD44 molecules in ovarian cancer cell lines. | 1995 | 38 |
| 13 | 1993 | 67 | |
| 14 | 1991 | 7 | |
| 15 | 1990 | 88 | |
| 16 | 1989 | 59 | |
| 17 | 1989 | 1 | |
| 18 | Monocytes enhance gamma-interferon-induced inhibition of myeloid progenitor cell growth through secretion of tumor necrosis factor. | 1988 | 18 |
| 19 | 1985 | 233 | |
| 20 | 1985 | 28 |
About S A Cannistra
S A Cannistra is a scholar working on Reproductive Medicine, Oncology and Immunology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Immune Response and Inflammation (5 papers), Immune Cell Function and Interaction (4 papers), PARP inhibition in cancer therapy (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Reproductive Medicine (236 citations), Immunology (368 citations) and Hematology (141 citations). S A Cannistra has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Thomas Ströbel, H Levine, James D. Griffin, F. Herrmann, Linda J. Swanson, Jonathan M. Niloff, Yu‐Tzu Tai, J D Griffin, Graziella M. Abu‐Jawdeh and P Groshek. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.